News

Filter

176 to 185 of 97212 results

AusBiotech argues for boosting commercial returns from research

05-12-2014

Trade group AusBiotech has made a submission to the Australian federal government’s consultation regarding…

AustraliaBiotechnologyFinancialPoliticsResearch

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

05-12-2014

The current pipeline of treatments for Parkinson’s disease is a site of great innovation, with 37%…

GBI ResearchGeriatricsNeurologicalPharmaceuticalResearch

US FDA approves new indication for Incyte’s Jakafi

US FDA approves new indication for Incyte’s Jakafi

05-12-2014

The US Food and Drug Administration yesterday approved a new use for Incyte Corp’s Jakafi (ruxolitinib)…

BiotechnologyIncyteJakafiOncologyRegulationUSA

GlaxoSmithKline abandons plans to divest Established Products portfolio

05-12-2014

In what has come as something of a surprise, UK pharma major GlaxoSmithKline has abandoned its plan to…

EuropeGlaxoSmithKlineMergers & AcquisitionsNorth AmericaPharmaceutical

FDA guidance for prospective ANDA sponsors

FDA guidance for prospective ANDA sponsors

04-12-2014

The US Food and Drug Administration has issued new guidance in its efforts to assist in certain circumstances…

FDAGenericsPharmaceutical sciencesRegulationUSA

Government action needed to slash prices for hepatitis C treatments, says US advocacy

Government action needed to slash prices for hepatitis C treatments, says US advocacy

04-12-2014

The US federal government should act to dramatically lower the cost of new and prohibitively pricey medications…

Anti-viralsBiotechnologyGilead SciencesPricingSovaldiUSA

US sales of Sanofi/Regeneron’s dupilumab for atopic dermatitis could exceed $1.3 billion by 2022, says analyst

04-12-2014

The first biologic to treat atopic dermatitis, French pharma major Sanofi (Euronext: SAN) and US biotech…

BiotechnologyDermatologicalsdupilumabMarkets & MarketingRegeneron PharmaceuticalsSanofiUSA

PHARMAC secures significant savings for New Zealand’s DHBs on biologic drug

04-12-2014

A new agreement for a high cost biologic drug will yield considerable savings for District Health Boards…

Anti-Arthritics/RheumaticsBiosimilarsBiotechnologyinfliximabJohnson & JohnsonNew ZealandPricingRemicade

Recently-announced timeline of UK Patent Box changes helps address uncertainty, says patent attorney

04-12-2014

Following UK Chancellor of the Exchequer George Osborne’s confirmation of an overhaul of the Patent…

FinancialPatentsPharmaceuticalResearchUK

176 to 185 of 97212 results

Back to top